PMID: 9187431Jan 1, 1997Paper

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma

Annals of Oncology : Official Journal of the European Society for Medical Oncology
M de WitD K Hossfeld

Abstract

PET using 18fluorodesoxyglucose (FDG) may offer the possibility of differentiating vital from necrotic residual masses. Seventeen patients with HD and 17 patients with NHL underwent FDG-PET following therapy. According to staging by routine methods at diagnosis, 7 patients presented stage I, 13 stage II, 5 stage III, and 9 stage IV. A dose of 250-400 MBq FDG was injected and whole-body PET was performed 30-60 minutes later. Residual mass was found in 32 patients with routine methods. FDG-PET was negative in 17 patients, who were considered to be in CR. None of them relapsed (median follow-up 63 weeks ). FDG-PET was positive in 17 patients. Sixteen patients had residual mass with routine methods. Four patients received radiation after PET. Their median follow-up is 58 weeks without relapse. Two other patients with lasting CR had FDG uptake outside the residual mass--one with confirmed pneumonia. Five patients had histologically confirmed lymphoma, 2 patients relapsed according to routine methods. One patient is likely to be false positive because of fracture at lymphoma site. Seven of 10 patients with FDG uptake in the residual mass after completed therapy relapsed. According to routine restaging, 2 patients achieved CR. In 1 pa...Continue Reading

Citations

Jun 17, 2006·European Journal of Nuclear Medicine and Molecular Imaging·N George Mikhaeel
Apr 11, 2001·Current Oncology Reports·B Coiffier
Jul 24, 2002·Seminars in Roentgenology·Elma Abella-Columna, Peter E Valk
Mar 4, 2000·Advanced Drug Delivery Reviews·A BhatnagarA Alavi
Jun 8, 2001·International Journal of Radiation Oncology, Biology, Physics·R B WilderJ D Cox
Aug 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Sarah S Donaldson
Sep 6, 2003·International Journal of Radiation Oncology, Biology, Physics·William C LavelyDennis E Hallahan
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·N R MaiseyL Bishop
Jun 23, 2000·Critical Reviews in Oncology/hematology·P SoubeyranH Eghbali
May 23, 2001·Critical Reviews in Oncology/hematology·J N TalbotF Montravers
Jun 23, 2000·Critical Reviews in Oncology/hematology·H EghbaliP Richaud
Oct 1, 2003·Clinical Positron Imaging : Official Journal of the Institute for Clinical P.E.T·Wolfgang Römer, Markus Schwaiger
May 24, 2000·Nuclear Medicine Communications·T O Nunan, S F Hain
Apr 7, 2007·Nuclear Medicine Communications·Anna M Kirby, N George Mikhaeel
Oct 6, 2007·Blood·Thomas C KweeRutger A J Nievelstein
Sep 17, 2008·Radiation Oncology·Nidhi SharmaRoger Macklis
Jul 28, 2006·Annals of Hematology·Solène QuerellouOlivier Couturier
Jan 1, 2012·PET Clinics·Juliano Julio CerciStefano Fanti
May 20, 2003·Acta medica Austriaca·P MikoschP Lind
Jun 22, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Xiaoxiao HeZhen Cheng
Feb 13, 2002·Seminars in Nuclear Medicine·Roland HustinxAbass Alavi
Apr 20, 2005·European Journal of Radiology·Alexander BechererKurt Kletter
Sep 15, 2004·Critical Reviews in Oncology/hematology·Martin HutchingsLena Specht
Jun 18, 2004·Seminars in Nuclear Medicine·Ora IsraelRachel Bar-Shalom
Jun 18, 1998·Primary Care·R L Wahl
Feb 8, 2005·Radiologic Clinics of North America·Hossein JadvarBarry L Shulkin
Aug 16, 2005·Seminars in Nuclear Medicine·Guy JerusalemGeorges Fillet
Aug 21, 2007·Seminars in Nuclear Medicine·Hossein JadvarBarry L Shulkin
Jul 16, 2008·Radiologic Clinics of North America·Andrei IagaruSanjiv Sam Gambhir
Aug 17, 2010·Clinical Lymphoma, Myeloma & Leukemia·Pareen ShenoyChristopher R Flowers
Sep 15, 1999·Lancet·J F Eary
Jan 31, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·M J O'DohertyS Schey
Jul 24, 2004·Internal Medicine Journal·S S FooA M Scott
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Malik E JuweidUNKNOWN Imaging Subcommittee of International Harmonization Project in Lymphoma

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
N G MikhaeelM J O'Doherty
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
O LangM L Sautter-Bihl
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
N R MaiseyL Bishop
© 2021 Meta ULC. All rights reserved